$200 Million Funding For Universal Flu Shot Development
CDC confirms 19 influenza related pediatric fatalities during 2019-2020 flu season
Within the U.S. government’s year-end spending legislation was a $200 million dollar funding allocation to continue the research for creating a universal influenza vaccine.
The legislation calls for a total investment of $1 billion, with $200,000,000 allocated for each of fiscal years 2020 through 2024.
President Donald Trump signed the $1.4 trillion spending legislation on December 20, 2019, which includes a boost in domestic spending for healthcare backed by Democrats.
According to a press release published by Senator Edward J. Markey, ‘the National Institutes of Health (NIH) began its 1st clinical trial of an innovative universal influenza vaccine candidate.’
Senator Markey and his colleagues previously introduced the Flu Vaccine Act and were able to secure a $100 million and $140 million for fiscal years 2018 and 2019, respectively, for universal flu vaccine research at the National Institute of Allergy and Infectious Diseases within the NIH.
This is good news since influenza viruses cost the nation about $10.4 billion in direct medical costs annually and $87 billion in total economic burden.
“The flu is an equal opportunity menace,” continued Senator Markey.
“We must enhance our ability to predict the right strain for the next season, produce a more optimal vaccine, and protect all Americans against all strains of this virus.”
“With increased research funding, hard-working healthcare providers, and brilliant scientific investigators, we are the closest we have ever been to ensuring a flu-free future,” concluded Senator Markey.
Universal influenza vaccine news
- Universal Flu Shot Remains Elusive
- NIAID Agrees to Test Universal Flu Vaccine Candidate
- ‘How To Triple Flu Shot Effectiveness’ Explained
- Universal Flu Vaccine Targets the Stalk Portion of the Protein
- $200 Million Dollar Grant Awarded for Flu Shot Development
Vaccination with traditional inactivated influenza vaccines or live-attenuated influenza vaccines remains the main strategy in the control of annual flu epidemics.
Furthermore, they do not offer protection against new influenza viruses that have shifted, commented researchers in a February 2019 study.
The continual antigenic drift of seasonal circulating influenza viruses causes the antigenic mismatch that requires a yearly reformulation of seasonal influenza vaccines, reported these researchers.
However, the US Centers for Disease Control and Prevention (CDC) says ‘It’s not too late to get vaccinated.’
‘The CDC suggests everyone 6 months of age and older should get a flu vaccine every season, with rare exceptions. An annual flu shot is always the best way to protect yourself from the various influenza viruses.’
Furthermore, if you do come down with the flu, antiviral medications are an important addition to the flu vaccine to help control the health impact of having the flu.
‘Almost all influenza viruses tested this season are susceptible to the FDA-approved influenza antiviral medications recommended for use in the USA for the 2019-2020 flu season’ said the CDC on December 20, 2019.
Flu shots and influenza medications are available at most pharmacies in the USA.
Since any vaccine can cause a side effect, vaccination decisions should be part of an ongoing discussion between healthcare providers and patients, says the CDC.
Influenza vaccine research news published by Precision Vaccinations.